LRP2 and cancer: A pan-cancer study found that LRP2 mutations were linked with increased immune cell infiltration, immune checkpoint gene expression, and significant enrichment of immune-related signaling pathways, as well as a better prognosis, compared to individuals who did not have LRP2 mutations (24).